drugset / Trial / NCT06331533
Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea
RandomizedSingle-groupDouble-blindTreatment
Summary
Investigation of the effectiveness of intradermal botulinum toxin A treatment in the treatment of erythematotelangiectatic rosacea (ETR) using clinical, biophysical, dermatoscopic and videocapillaroscopy.
Timeline
- Start
- 2022-11-01
- Primary completion
- 2023-05-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 15 iu | Other |